Price T Rowe Associates Inc Elanco Animal Health Inc Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 395,198 shares of ELAN stock, worth $6.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
395,198
Previous 401,915 1.67%
Holding current value
$6.89 Million
Previous $4.22 Million 33.71%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$8.1 - $14.3 $54,407 - $96,053
-6,717 Reduced 1.67%
395,198 $5.64 Million
Q1 2025

May 14, 2025
SELL
$10.04 - $12.47 $1.55 Million - $1.93 Million
-154,557 Reduced 27.77%
401,915 $4.22 Million
Q4 2024

Feb 14, 2025
SELL
$11.63 - $14.67 $28.8 Million - $36.4 Million
-2,479,034 Reduced 81.67%
556,472 $6.74 Million
Q3 2024

Nov 14, 2024
SELL
$11.85 - $15.47 $297 Million - $387 Million
-25,032,216 Reduced 89.19%
3,035,506 $44.6 Million
Q2 2024

Aug 14, 2024
BUY
$12.93 - $18.45 $76.7 Million - $109 Million
5,928,704 Added 26.78%
28,067,722 $405 Million
Q1 2024

May 15, 2024
BUY
$14.37 - $16.46 $12.2 Million - $14 Million
852,281 Added 4.0%
22,139,018 $360 Million
Q4 2023

Feb 14, 2024
BUY
$8.6 - $14.94 $11.7 Million - $20.4 Million
1,365,731 Added 6.86%
21,286,737 $317 Million
Q3 2023

Nov 14, 2023
BUY
$9.81 - $12.62 $24.5 Million - $31.5 Million
2,494,084 Added 14.31%
19,921,006 $224 Million
Q2 2023

Aug 14, 2023
BUY
$8.08 - $10.37 $849,846 - $1.09 Million
105,179 Added 0.61%
17,426,922 $175 Million
Q1 2023

May 15, 2023
SELL
$8.79 - $14.58 $11.7 Million - $19.4 Million
-1,329,896 Reduced 7.13%
17,321,743 $163 Million
Q4 2022

Feb 14, 2023
SELL
$11.49 - $13.65 $96.3 Million - $114 Million
-8,379,249 Reduced 31.0%
18,651,639 $228 Million
Q3 2022

Nov 14, 2022
BUY
$12.41 - $32.42 $60.5 Million - $158 Million
4,872,640 Added 21.99%
27,030,888 $335 Million
Q2 2022

Aug 15, 2022
SELL
$19.63 - $26.62 $243 Million - $329 Million
-12,354,858 Reduced 35.8%
22,158,248 $435 Million
Q1 2022

May 16, 2022
BUY
$24.65 - $29.0 $1.18 Million - $1.39 Million
48,052 Added 0.14%
34,513,106 $900 Million
Q4 2021

Feb 14, 2022
SELL
$27.74 - $34.09 $347 Million - $426 Million
-12,502,789 Reduced 26.62%
34,465,054 $978 Million
Q3 2021

Nov 15, 2021
BUY
$29.2 - $36.72 $5.49 Million - $6.91 Million
188,117 Added 0.4%
46,967,843 $1.5 Billion
Q2 2021

Aug 16, 2021
BUY
$28.76 - $35.98 $144 Million - $180 Million
5,006,187 Added 11.98%
46,779,726 $1.62 Billion
Q1 2021

May 17, 2021
BUY
$27.85 - $34.49 $9.27 Million - $11.5 Million
332,959 Added 0.8%
41,773,539 $1.23 Billion
Q4 2020

Feb 16, 2021
BUY
$27.53 - $33.79 $1.14 Billion - $1.4 Billion
41,440,580 New
41,440,580 $1.27 Billion

Others Institutions Holding ELAN

# of Institutions
417
Shares Held
487M
Call Options Held
868K
Put Options Held
1.42M
View Full List

About Elanco Animal Health Inc

ELAN Quotes by TradingView
  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $8.26B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email